Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × DOXO-EMCH × Clear all

NCT02200757 2024-06-25

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

Phase 2 Completed

135 enrolled 11 charts

Small Cell Lung Carcinoma

NCT00472771 2012-02-09

INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

Phase 2 Withdrawn

Small Cell Lung Carcinoma